Open Access
REVIEW
ZHIZHENG ZHANG1,#, TAO LI2,#, YUAN LI3, XI WANG4, HAO LIU5, XINYU SHEN5, ANN XU6, TIANSONG XIA1,*, BO XU7,*
1 Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China
2 Department of Pathology, Jiangsu Provincial People’s Hospital, Nanjing, 210029, China
3 Department of Gynaecology and Obstetrics, No. 908th Hospital of Chinese PLA Joint Logistic Support Force, Nanchang, 330000, China
4 First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China
5 Department of Outpatient, Eastern Theater General Hospital, Nanjing, 210016, China
6 Zhejiang ZhongNuoMei Biotech Limited Company, Hangzhou, 310000, China
7 School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China
* Corresponding Author: TIANSONG XIA. Email: ; BO XU. Email:
# These authors contributed equally to this work
(This article belongs to the Special Issue: Novel Targets and Biomarkers in Solid Tumors)
Oncology Research https://doi.org/10.32604/or.2024.050505
Received 08 February 2024; Accepted 15 July 2024; Published online 09 September 2024
View
Download
Like
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
Yudie Yang, Xia Zhang, Yajie Gao,...MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer
Adilijiang Maimaitiming, Ailijiang...miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Xiao-Na Li, Hong Yang, Tao YangLoss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review
Jian Zhao, Xia Zhang, Xiaonan...